MedTrace Logo

Mechanisms and Biomarkers for Tumor Immunogenicity Modulation in Cervical Cancer

NCT05188716 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-02-06

No results posted yet for this study

Summary

This study aims to investigate mechanisms that dictate tumor immunogenicity and to explore potential biomarkers that could help predict changes of tumor immunogenicity and therapeutic response in patients with cervical cancer after chemoradiotherapy or surgery.

Conditions

Sponsors & Collaborators

  • Chuangzhen Chen

    lead OTHER

Principal Investigators

  • Chuangzhen Chen, MD · Affiliated Cancer Hospital of Shantou University Medical College

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-10
Primary Completion
2021-10-13
Completion
2022-01-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05188716 on ClinicalTrials.gov